{"pmid":32483288,"title":"Containment of a traceable COVID-19 outbreak among healthcare workers at a hematopoietic stem cell transplantation unit.","text":["Containment of a traceable COVID-19 outbreak among healthcare workers at a hematopoietic stem cell transplantation unit.","Bone Marrow Transplant","Buchtele, N","Rabitsch, W","Knaus, H A","Wohlfarth, P","32483288"],"journal":"Bone Marrow Transplant","authors":["Buchtele, N","Rabitsch, W","Knaus, H A","Wohlfarth, P"],"date":"2020-06-03T11:00:00Z","year":2020,"_id":"32483288","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1038/s41409-020-0958-6","topics":["Prevention"],"weight":1,"_version_":1668532114864209921,"score":9.490897,"similar":[{"pmid":32367075,"pmcid":"PMC7197237","title":"COVID-19 pandemic and impact on hematopoietic stem cell transplantation.","text":["COVID-19 pandemic and impact on hematopoietic stem cell transplantation.","Bone Marrow Transplant","Sahu, Kamal Kant","Siddiqui, Ahmad Daniyal","Cerny, Jan","32367075"],"journal":"Bone Marrow Transplant","authors":["Sahu, Kamal Kant","Siddiqui, Ahmad Daniyal","Cerny, Jan"],"date":"2020-05-06T11:00:00Z","year":2020,"_id":"32367075","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1038/s41409-020-0913-6","topics":["Prevention"],"weight":1,"_version_":1666138496282132480,"score":93.185036},{"pmid":32458703,"title":"Hematopoietic stem cell transplantation dilemma during the COVID-19 era.","text":["Hematopoietic stem cell transplantation dilemma during the COVID-19 era.","Future Oncol","Samaha, Ramy","Kattan, Joseph","32458703"],"journal":"Future Oncol","authors":["Samaha, Ramy","Kattan, Joseph"],"date":"2020-05-28T11:00:00Z","year":2020,"_id":"32458703","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.2217/fon-2020-0414","keywords":["covid-19","coronavirus","hematology","hematopoietic stem cell transplantation","oncologist","oncology"],"topics":["Prevention"],"weight":1,"_version_":1667967698961694720,"score":93.185036},{"pmid":32389803,"title":"Hematopoietic cell transplantation with cryopreserved grafts for severe aplastic anemia.","text":["Hematopoietic cell transplantation with cryopreserved grafts for severe aplastic anemia.","The COVID-19 pandemic and the ensuing barriers to the collection and transport of donor cells, it is often necessary to collect and cryopreserve grafts before initiation of transplant conditioning. The effect on transplant outcomes in non-malignant disease is unknown. This analysis examined the effect of cryopreservation of related and unrelated donor grafts for transplantation for severe aplastic anemia in the US during 2013-2019. Included are 52 recipients of cryopreserved grafts who were matched for age, donor type, and graft type to 194 recipients who received non-cryopreserved grafts. Marginal Cox regression models were built to study the effect of cryopreservation and other risk factors associated with outcomes. We recorded higher 1-year rates of graft failure (HR 2.26, 95% CI 1.17 - 4.35, p=0.01) and of 1-year overall mortality (HR 3.13, 95% CI 1.60 - 6.11, p=0.0008) after transplantation of cryopreserved compared to non-cryopreserved grafts with adjustment for sex, performance score, comorbidity, cytomegalovirus serostatus, and ABO blood group match). Acute and chronic GVHD did not differ between groups. Adjusted probabilities of 1-year survival were 73% (95% 60 - 84) and 91% (95% CI 86 - 94) with cryopreserved and non-cryopreserved grafts, respectively. These data support the use of non-cryopreserved grafts, when possible, for severe aplastic anemia.","Biol Blood Marrow Transplant","Eapen, Mary","Zhang, Mei-Jie","Tang, Xiao-Ying","Lee, Stephanie J","Fei, Ming-Wei","Wang, Hai-Lin","Hebert, Kyle M","Arora, Mukta","Chhabra, Saurabh","Devine, Steven M","Hamadani, Mehdi","D'Souza, Anita","Pasquini, Marcelo C","Phelan, Rachel","Rizzo, J Douglas","Saber, Wael","Shaw, Bronwen E","Weisdorf, Daniel J","Horowitz, Mary M","32389803"],"abstract":["The COVID-19 pandemic and the ensuing barriers to the collection and transport of donor cells, it is often necessary to collect and cryopreserve grafts before initiation of transplant conditioning. The effect on transplant outcomes in non-malignant disease is unknown. This analysis examined the effect of cryopreservation of related and unrelated donor grafts for transplantation for severe aplastic anemia in the US during 2013-2019. Included are 52 recipients of cryopreserved grafts who were matched for age, donor type, and graft type to 194 recipients who received non-cryopreserved grafts. Marginal Cox regression models were built to study the effect of cryopreservation and other risk factors associated with outcomes. We recorded higher 1-year rates of graft failure (HR 2.26, 95% CI 1.17 - 4.35, p=0.01) and of 1-year overall mortality (HR 3.13, 95% CI 1.60 - 6.11, p=0.0008) after transplantation of cryopreserved compared to non-cryopreserved grafts with adjustment for sex, performance score, comorbidity, cytomegalovirus serostatus, and ABO blood group match). Acute and chronic GVHD did not differ between groups. Adjusted probabilities of 1-year survival were 73% (95% 60 - 84) and 91% (95% CI 86 - 94) with cryopreserved and non-cryopreserved grafts, respectively. These data support the use of non-cryopreserved grafts, when possible, for severe aplastic anemia."],"journal":"Biol Blood Marrow Transplant","authors":["Eapen, Mary","Zhang, Mei-Jie","Tang, Xiao-Ying","Lee, Stephanie J","Fei, Ming-Wei","Wang, Hai-Lin","Hebert, Kyle M","Arora, Mukta","Chhabra, Saurabh","Devine, Steven M","Hamadani, Mehdi","D'Souza, Anita","Pasquini, Marcelo C","Phelan, Rachel","Rizzo, J Douglas","Saber, Wael","Shaw, Bronwen E","Weisdorf, Daniel J","Horowitz, Mary M"],"date":"2020-05-12T11:00:00Z","year":2020,"_id":"32389803","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1016/j.bbmt.2020.04.027","keywords":["cryopreserved graft","severe aplastic anemia"],"locations":["US"],"countries":["United States"],"countries_codes":["USA|United States"],"topics":["Prevention"],"weight":1,"_version_":1666528580263215104,"score":69.695786},{"pmid":32404975,"title":"The challenge of COVID-19 and hematopoietic cell transplantation; EBMT recommendations for management of hematopoietic cell transplant recipients, their donors, and patients undergoing CAR T-cell therapy.","text":["The challenge of COVID-19 and hematopoietic cell transplantation; EBMT recommendations for management of hematopoietic cell transplant recipients, their donors, and patients undergoing CAR T-cell therapy.","The new coronavirus SARS-CoV-2 has rapidly spread over the world causing the disease by WHO called COVID-19. This pandemic poses unprecedented stress on the health care system including programs performing allogeneic and autologous hematopoietic cell transplantation (HCT) and cellular therapy such as with CAR T cells. Risk factors for severe disease include age and predisposing conditions such as cancer. The true impact on stem cell transplant and CAR T-cell recipients in unknown. The European Society for Blood and Marrow Transplantation (EBMT) has therefore developed recommendations for transplant programs and physicians caring for these patients. These guidelines were developed by experts from the Infectious Diseases Working Party and have been endorsed by EBMT's scientific council and board. This work intends to provide guidelines for transplant centers, management of transplant candidates and recipients, and donor issues until the COVID-19 pandemic has passed.","Bone Marrow Transplant","Ljungman, Per","Mikulska, Malgorzata","de la Camara, Rafael","Basak, Grzegorz W","Chabannon, Christian","Corbacioglu, Selim","Duarte, Rafael","Dolstra, Harry","Lankester, Arjan C","Mohty, Mohamad","Montoto, Silvia","Murray, John","Peffault de Latour, Regis","Snowden, John A","Yakoub-Agha, Ibrahim","Verhouven, Bregje","Kroger, Nicolaus","Styczynski, Jan","32404975"],"abstract":["The new coronavirus SARS-CoV-2 has rapidly spread over the world causing the disease by WHO called COVID-19. This pandemic poses unprecedented stress on the health care system including programs performing allogeneic and autologous hematopoietic cell transplantation (HCT) and cellular therapy such as with CAR T cells. Risk factors for severe disease include age and predisposing conditions such as cancer. The true impact on stem cell transplant and CAR T-cell recipients in unknown. The European Society for Blood and Marrow Transplantation (EBMT) has therefore developed recommendations for transplant programs and physicians caring for these patients. These guidelines were developed by experts from the Infectious Diseases Working Party and have been endorsed by EBMT's scientific council and board. This work intends to provide guidelines for transplant centers, management of transplant candidates and recipients, and donor issues until the COVID-19 pandemic has passed."],"journal":"Bone Marrow Transplant","authors":["Ljungman, Per","Mikulska, Malgorzata","de la Camara, Rafael","Basak, Grzegorz W","Chabannon, Christian","Corbacioglu, Selim","Duarte, Rafael","Dolstra, Harry","Lankester, Arjan C","Mohty, Mohamad","Montoto, Silvia","Murray, John","Peffault de Latour, Regis","Snowden, John A","Yakoub-Agha, Ibrahim","Verhouven, Bregje","Kroger, Nicolaus","Styczynski, Jan"],"date":"2020-05-15T11:00:00Z","year":2020,"_id":"32404975","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1038/s41409-020-0919-0","topics":["Prevention"],"weight":1,"_version_":1666802845412753408,"score":68.794},{"pmid":32353701,"pmcid":"PMC7151275","title":"Facing COVID-19 in the hematopoietic cell transplant setting: A new challenge for transplantation physicians.","text":["Facing COVID-19 in the hematopoietic cell transplant setting: A new challenge for transplantation physicians.","Blood Cells Mol Dis","Sahu, Kamal Kant","Jindal, Vishal","Siddiqui, Ahmad Daniyal","Cerny, Jan","32353701"],"journal":"Blood Cells Mol Dis","authors":["Sahu, Kamal Kant","Jindal, Vishal","Siddiqui, Ahmad Daniyal","Cerny, Jan"],"date":"2020-05-01T11:00:00Z","year":2020,"_id":"32353701","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1016/j.bcmd.2020.102439","topics":["Prevention"],"weight":1,"_version_":1666138495719047168,"score":64.267334}]}